Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Galectin Therapeutics Inc

+ Add to Watchlist

GALTU:US

7.7000 USD 0.7200 8.55%

As of 20:10:00 ET on 02/03/2015.

Snapshot for Galectin Therapeutics Inc (GALTU)

Open: 7.7000 Day's Range: 7.7000 - 7.7000 Volume: 100
Previous Close: 8.4200 52wk Range: 7.7000 - 50.0500 1-Yr Rtn: -

Stock Chart for GALTU

No chart data available.
  • GALTU:US 7.7000
  • 1D
  • 1M
  • 1Y
8.4200
Interactive GALTU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GALTU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 141.00
Shares Outstanding (M) 18.31
30 Day Average Volume 10
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GALTU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GALTU

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.

James C CzirrChairman/Co-FounderPeter G TraberPresident/CEO/Chief Medical Ofcr
Jack W CallicuttChief Financial OfficerHarold H ShlevinChief Operating Officer
More Company Profile & Key Executives for GALTU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil